6.61  -0.34 (-4.89%)		03-23 16:00
Open: 6.94 High: 7.3 Volume: 75,435		Pre. Close: 6.95 Low: 6.5 Market Cap: 179(M)

Short term
Mid term
Targets	6-month :	8.58	1-year :	10.02
Resists	First :	7.34	Second :	8.58
Pivot price	6.32
Supports	First :	6.08	Second :	5.3
MAs	MA(5) :	6.88	MA(20) :	6.18
	MA(100) :	6.02	MA(250) :	16.14
MACD	MACD :	0.2	Signal :	0.1
%K %D	K(14,3) :	73.7	D(3) :	81.2
RSI	RSI(14): 58.5
52-week	High :	46.04	Low :	4.9

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ QTI ] has closed below upper band by 34.0%. Bollinger Bands are 72.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 86 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	7.31 - 7.35	7.35 - 7.39
Low:	6.4 - 6.45	6.45 - 6.49
Close:	6.54 - 6.62	6.62 - 6.67

QT Imaging Holdings, Inc. engages in the manufacturing, research, and development of automated breast imaging system for producing high-resolution transmission ultrasound images. It offers QT Ultrasound Breast Scanner that provides reflection-mode and transmission-mode images of a patient's breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.

Wed, 18 Mar 2026
QT Imaging schedules investor call on 2025 results for March 25 - Stock Titan

Tue, 10 Mar 2026
QT Imaging Receives FDA Clearance for Its Breast Acoustic CT Scanner Enhanced Configuration to Improve Posterior Breast Imaging Coverage - Business Wire

Thu, 05 Mar 2026
QTI SEC Filings - QT Imaging Holdings 10-K, 10-Q, 8-K Forms - Stock Titan

Wed, 04 Mar 2026
USC breast imaging chief to advise QT Imaging on radiation-free 3D scans - Stock Titan

Mon, 23 Feb 2026
QT Imaging Achieves Major Reimbursement Milestone with AMA Category III CPT Code for 3D Breast Ultrasound Tomography - BioSpace

Wed, 18 Feb 2026
QT Imaging Reports Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results - Business Wire

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	12 (M)
Shares Float	8 (M)
Held by Insiders	28.4 (%)
Held by Institutions	9.6 (%)
Shares Short	171 (K)
Shares Short P.Month	88 (K)

EPS	-2.01
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.46
Profit Margin	-111.5 %
Operating Margin	-8.5 %
Return on Assets (ttm)	-19.1 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	877.5 %
Gross Profit (p.s.)	0.71
Sales Per Share	1.58
EBITDA (p.s.)	-0.37
Qtrly Earnings Growth	0 %
Operating Cash Flow	-9 (M)
Levered Free Cash Flow	-9 (M)

PE Ratio	-3.29
PEG Ratio	0
Price to Book value	14.06
Price to Sales	4.16
Price to Cash Flow	-8.81

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.